![]()
|
|
||||||||
Peptide1-42 Suppresses
Acetylcholine Synthesis
(Received for publication, July 15, 1996, and in revised form, September 23, 1996)
From the Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida-shi, Tokyo 194, Japan
We show here that amyloid
peptide1-42 (A
1-42) may play a key role in
the pathogenesis of the cholinergic dysfunction seen in Alzheimer's
disease (AD), in addition to its putative role in amyloid plaque
formation. A
1-42 freshly solubilized in water (non-aged
A
1-42), which was not neurotoxic without preaggregation, suppressed acetylcholine (ACh) synthesis in cholinergic neurons at very low concentrations (10-100 nM), although
non-aged A
1-40 was ineffective. Non-aged
A
1-42 impaired pyruvate dehydrogenase (PDH) activity by
activating mitochondrial
protein kinase I/glycogen synthase
kinase-3
, as we have already shown in hippocampal neurons (Hoshi,
M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., Kondo, S.,
Saitoh, Y., Ishiguro, K., Hoshino, T., and Imahori, K. (1996)
Proc. Natl. Acad. Sci. U. S. A. 93, 2719-2723). Neither
choline acetyltransferase activity nor choline metabolism was affected.
Therefore, the major cause of reduced ACh synthesis was considered to
be an inadequate supply of acetyl-CoA owing to PDH impairment. Soluble
A
1-42 increases specifically in AD brain (Kuo, Y.-M.,
Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B.,
Murdoch, G. H., Ball, M. J., and Roher, A. E. (1996) J. Biol. Chem. 271, 4077-4081). This increase in soluble
A
1-42 may disturb cholinergic function, leading to the
deterioration of memory and cognitive function that is characteristic
of AD.
This article has been cited by other articles:
![]() |
J. Wu, Y.-P. Kuo, A. A. George, L. Xu, J. Hu, and R. J. Lukas {beta}-Amyloid Directly Inhibits Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Heterologously Expressed in Human SH-EP1 Cells J. Biol. Chem., September 3, 2004; 279(36): 37842 - 37851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhong, Z. Gu, X. Wang, H. Jiang, J. Feng, and Z. Yan Impaired Modulation of GABAergic Transmission by Muscarinic Receptors in a Mouse Transgenic Model of Alzheimer's Disease J. Biol. Chem., July 11, 2003; 278(29): 26888 - 26896. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gu, P. Zhong, and Z. Yan Activation of Muscarinic Receptors Inhibits beta -Amyloid Peptide-induced Signaling in Cortical Slices J. Biol. Chem., May 2, 2003; 278(19): 17546 - 17556. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dobransky, D. Brewer, G. Lajoie, and R. J. Rylett Phosphorylation of 69-kDa Choline Acetyltransferase at Threonine 456 in Response to Amyloid-beta Peptide 1-42 J. Biol. Chem., February 14, 2003; 278(8): 5883 - 5893. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Sun and D. L. Alkon Impairment of Hippocampal CA1 Heterosynaptic Transformation and Spatial Memory by beta -Amyloid25-35 J Neurophysiol, May 1, 2002; 87(5): 2441 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Strohman Maneuvering in the Complex Path from Genotype to Phenotype Science, April 26, 2002; 296(5568): 701 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kashiwaya, T. Takeshima, N. Mori, K. Nakashima, K. Clarke, and R. L. Veech D-beta -Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease PNAS, May 9, 2000; 97(10): 5440 - 5444. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takashima, M. Murayama, O. Murayama, T. Kohno, T. Honda, K. Yasutake, N. Nihonmatsu, M. Mercken, H. Yamaguchi, S. Sugihara, et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau PNAS, August 4, 1998; 95(16): 9637 - 9641. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Torroja, D. Ortuno-Sahagun, A. Ferrus, B. Hammerle, and J. A. Barbas scully, an Essential Gene of Drosophila, is Homologous to Mammalian Mitochondrial Type II L-3-hydroxyacyl-CoA Dehydrogenase/Amyloid-beta Peptide-binding Protein J. Cell Biol., May 18, 1998; 141(4): 1009 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Pedersen, Q. Guo, B. K. Hartman, and M. P. Mattson Nerve Growth Factor-independent Reduction in Choline Acetyltransferase Activity in PC12 Cells Expressing Mutant Presenilin-1 J. Biol. Chem., September 5, 1997; 272(36): 22397 - 22400. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |